Estados financieros detallados de Nkarta, Inc. (NKTX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.87, NKTX presenta beneficios negativos (P/E no significativo) y un ROE del -39.64%. La capitalización bursátil es de $205M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $6.5M | $115385 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $4.3M | $17217 | 0 | 0 | 0 | $5.9M | 0 | $9.2M |
| Beneficio Bruto | $2.3M | $98168 | 0 | 0 | 0 | -$5.9M | 0 | -$9.2M |
| I+D | $4.3M | $17.2M | $36.2M | $63.4M | $90.9M | $90.9M | $96.7M | $90.4M |
| Generales y Administrativos | $2.7M | $5.2M | $15.3M | $23.0M | $28.1M | $34.9M | $31.4M | $31.6M |
| Gastos Operativos | $6.9M | $22.5M | $51.5M | $86.4M | $119.0M | $125.8M | $128.2M | $112.0M |
| Beneficio Operativo | -$356449 | -$22.3M | -$51.5M | -$86.4M | -$119.0M | -$131.7M | -$128.2M | -$121.2M |
| EBITDA | -$91289 | -$20.0M | -$50.7M | -$84.3M | -$105.6M | -$120.5M | -$99.6M | -$94.9M |
| Gastos por Intereses | 0 | $473000 | 0 | 0 | $5.6M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$274503 | -$21.1M | -$91.4M | -$86.1M | -$113.8M | -$117.5M | -$108.8M | -$104.1M |
| Impuestos | 0 | $1.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$274503 | -$21.1M | -$91.4M | -$86.1M | -$113.8M | -$117.5M | -$108.8M | -$104.1M |
| BPA | $-0.01 | $-2.55 | $-1.59 | $-2.62 | $-2.61 | $-2.40 | $-1.60 | $-1.41 |
| BPA Diluido | $-0.01 | $-2.55 | $-1.59 | $-2.62 | $-2.61 | $-2.40 | $-1.60 | $-1.41 |
| Acciones en Circulación (Diluidas) | $50.3M | $9.0M | $31.8M | $32.9M | $43.6M | $49.0M | $67.9M | $74.0M |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $7.9M | $20.6M | $96.7M | $60.8M | $37.5M | $31.0M | $27.9M | $39.6M |
| Inversiones a Corto | 0 | $16.4M | $218.2M | $177.3M | $314.6M | $217.1M | $239.5M | $236.6M |
| Cuentas por Cobrar | $150000 | 0 | 0 | 0 | $1.3M | $200000 | $200000 | $2.0M |
| Inventario | $117290 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.2M | $37.5M | $318.8M | $245.8M | $360.7M | $253.1M | $273.3M | $282.5M |
| Inmovilizado Material | $1.3M | $10.2M | $17.9M | $24.5M | $107.7M | $119.3M | $110.7M | $101.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $9.6M | $48.4M | $337.6M | $273.9M | $472.9M | $378.9M | $501.2M | $404.2M |
| Cuentas por Pagar | $367172 | $1.9M | $1.2M | $1.1M | $1.8M | $3.7M | $638000 | $2.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $4.2M | 0 | 0 | 0 |
| Pasivos Corrientes | $2.1M | $8.2M | $8.8M | $12.9M | $22.0M | $23.3M | $18.9M | $22.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $15.0M | $73.9M | $16.4M | $22.9M | $100.7M | $105.6M | $93.2M | $91.9M |
| Reservas | -$5.6M | -$26.7M | -$118.0M | -$204.1M | -$317.9M | -$435.4M | -$544.2M | -$648.3M |
| Patrimonio Neto | -$5.4M | -$25.5M | $321.2M | $251.0M | $372.2M | $273.3M | $408.0M | $312.3M |
| Deuda Total | $12.7M | $7.3M | $8.9M | $12.5M | $82.9M | $88.3M | $80.3M | $76.4M |
| Deuda Neta | $4.8M | -$29.7M | -$306.0M | -$225.6M | -$269.2M | -$159.8M | -$187.1M | -$199.9M |
| Capital Circulante | $6.2M | $29.3M | $310.0M | $232.8M | $338.6M | $229.7M | $254.4M | $260.2M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$274503 | -$21.1M | -$91.4M | -$86.1M | -$113.8M | -$117.5M | -$108.8M | -$104.1M |
| Amortizaciones | $183214 | $401000 | $786000 | $1.8M | $2.6M | $5.9M | $2.2M | $4.6M |
| Compensación en Acciones | $182513 | $947000 | $6.7M | $14.5M | $16.9M | $17.2M | $16.7M | $8.6M |
| Cambio en Capital Circulante | -$5.3M | $2.2M | -$828000 | -$1.6M | $33.7M | $10.9M | -$12.2M | -$435000 |
| Flujo de Caja Operativo | -$5.2M | -$18.4M | -$43.5M | -$67.9M | -$57.0M | -$86.2M | -$99.7M | -$88.7M |
| Inversiones (CapEx) | -$757880 | -$1.9M | -$7.5M | -$5.0M | -$47.1M | -$28.1M | -$4.4M | -$1.2M |
| Adquisiciones | 0 | 0 | $202570 | -$37559 | $137578 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.9M | -$20.3M | -$51.0M | -$73.0M | -$104.1M | -$114.3M | -$104.1M | -$89.9M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -98.2% | -100.0% | ||||||
| Crecimiento Beneficio Neto (anual) | -7577.8% | -333.5% | +5.8% | -32.3% | -3.2% | +7.4% | +4.3% | |
| Crecimiento BPA (anual) | -46263.6% | +37.6% | -64.8% | +0.4% | +8.0% | +33.3% | +11.9% | |
| Cambio en Acciones (anual) | -82.1% | +254.0% | +3.3% | +32.8% | +12.3% | +38.5% | +9.0% | |
| Crecimiento FCF (anual) | -241.6% | -151.4% | -43.0% | -42.7% | -9.8% | +8.9% | +13.6% | |
| Margen Bruto | 35.1% | 85.1% | ||||||
| Margen Operativo | -5.4% | -19368.7% | ||||||
| Margen EBITDA | -1.4% | -17376.4% | ||||||
| Margen Neto | -4.2% | -18265.7% | ||||||
| Margen FCF | -90.7% | -17588.9% | ||||||
| Tasa Impositiva Efectiva | -0.0% | -8.6% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.12 | $-2.26 | $-1.60 | $-2.22 | $-2.39 | $-2.33 | $-1.53 | $-1.22 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $50.3M | $9.0M | $31.8M | $32.9M | $43.6M | $49.0M | $67.9M | $74.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -39.64% |
| Rentabilidad sobre capital invertido | -41.15% |
| Rentabilidad sobre activos | -34.75% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.30 |
| Ratio corriente | 7.98 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| P/E | -8709.09 | -18.78 | -38.66 | -5.86 | -2.30 | -2.75 | -1.56 | -1.31 |
| P/VC | -446.25 | -16.89 | 6.08 | 2.01 | 0.70 | 1.18 | 0.41 | 0.44 |
| P/V | 367.62 | 3729.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 35.1% | 85.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -5.4% | -19368.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -4.2% | -18265.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ALEC · APLT · CYBN · ELTX · FATE · FBRX · MOLN
Explorar sector: Healthcare · Biotechnology
Más secciones de NKTX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones